MYCN amplification predicts poor prognosis based on interphase fluorescence in situ hybridization analysis of bone marrow cells in bone marrow metastases of neuroblastoma

BACKGROUND: MYCN gene amplification is related to risk stratification. Therefore it is important to identify accurately the level of the MYCN gene as early as possible in neuroblastoma (NB); however, for patients with bone marrow (BM) metastasis who need chemotherapy before surgery, timely detection...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Cell Int
Main Authors: Yue, Zhi-Xia, Huang, Cheng, Gao, Chao, Xing, Tian-Yu, Liu, Shu-Guang, Li, Xing-Jun, Zhao, Qian, Wang, Xi-Si, Zhao, Wen, Jin, Mei, Ma, Xiao-Li
Format: Artigo
Language:Inglês
Published: BioMed Central 2017
Subjects:
Primary Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5374581/
https://ncbi.nlm.nih.gov/pubmed/28367105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-017-0412-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items